Drug Shortage Report for NALCROM
Report ID | 171702 |
Drug Identification Number | 00500895 |
Brand name | NALCROM |
Common or Proper name | NALCROM |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CROMOLYN SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 100 capsules |
ATC code | A07EB |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-10-12 |
Estimated end date | 2023-06-30 |
Actual end date | 2023-06-30 |
Shortage status | Resolved |
Updated date | 2023-07-01 |
Company comments | Replenishment supply is available to market. Intermittent supply constraints. Allocations are for protective measures. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-10-13 | English | Compare |
v2 | 2022-10-13 | French | Compare |
v3 | 2022-10-13 | English | Compare |
v4 | 2022-10-13 | French | Compare |
v5 | 2022-10-13 | English | Compare |
v6 | 2022-10-13 | French | Compare |
v7 | 2022-11-03 | English | Compare |
v8 | 2022-11-09 | English | Compare |
v9 | 2022-11-09 | French | Compare |
v10 | 2023-01-10 | English | Compare |
v11 | 2023-01-10 | French | Compare |
v12 | 2023-01-10 | French | Compare |
v13 | 2023-01-10 | English | Compare |
v14 | 2023-01-10 | French | Compare |
v15 | 2023-02-28 | English | Compare |
v16 | 2023-03-02 | English | Compare |
v17 | 2023-03-02 | French | Compare |
v18 | 2023-06-30 | English | Compare |
v19 | 2023-06-30 | French | Compare |
v20 | 2023-07-01 | English | Compare |
Showing 1 to 20 of 20